drugset / Trial / NCT03608514

Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.

NCT03608514

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the use of terlipressin compared to standard regimen in hepatic patients with septic shock. Another aim is to compare the mortality rate \& the effects on renal functions in both groups.

Timeline

Start
2018-07-01
Primary completion
2020-07
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 1 ug/kg Intravenous
Subject Terlipressin Peptide 2 ug/kg Intravenous

Indications

No indication recorded.